<DOC>
	<DOCNO>NCT01849952</DOCNO>
	<brief_summary>MicroRNAs ( miRNA ) molecular biomarkers post-transcriptionally control target gene . Deregulated miRNA expression observe diverse cancer . In high grade glioma , know glioblastoma , investigator identify oncogenic miRNA , miRNA-10b ( mir-10b ) express high level glioblastomas normal brain tissue . This study test hypothesis primary glioma sample mir-10b expression pattern serve prognostic diagnostic marker . This study also characterize phenotypic genotypic diversity glioma subclass . Furthermore , consider critical function anti-mir-10b blocking establish glioblastoma growth , investigator test vitro sensitivity individual primary tumor anti-mir-10b treatment . Tumor , blood cerebrospinal fluid sample obtain patient diagnosed gliomas period two year . These sample examine mir-10b expression level . Patient survival , well tumor grade genotypic variation correlate mir-10b expression level .</brief_summary>
	<brief_title>Evaluating Expression Levels MicroRNA-10b Patients With Gliomas</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Inclusion/ 18 year age Brain tumor ( ) resect clinical reason . Histological pathology confirmation tumor glial origin , WHO Grade II , III IV . Adequate tissue available processing determine Pathology . Adequate decision make ability review , discuss sign consent form allow tumor sample use future human brain tumor biology laboratory research . Determination capacity consent make one coinvestigators base clinical assessment . Patients opt standard treatment regimen disease well ongoing clinical trial eligible participate study . Standard care newlydiagnosed glioblastoma typically consist surgical resection follow radiotherapy concomitant temozolomide , follow adjuvant temozolomide chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>glioblastoma</keyword>
	<keyword>miRNA</keyword>
	<keyword>GBM</keyword>
	<keyword>astrocytoma</keyword>
</DOC>